Search research articles
Contact Us
Filters
Showing results (191-200 of 280) with videos related to
Page
of 28
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 16, 2010
A first-in-human study of conatumumab in adult patients with advanced solid tumors
Roy S Herbst, Razelle Kurzrock, David S Hong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 11, 2010
Phase I pharmacokinetic and pharmacodynamic study of the oral MAPK/ERK kinase inhibitor PD-0325901 in patients with advanced cancers
Patricia M LoRusso, Smitha S Krishnamurthi, John J Rinehart, et al.
IEEE ... International Conference on Rehabilitation Robotics : [Proceedings]
|
July 11, 2025
Effects of Visual and Verbal Feedback on Active Patient Participation During Robot-Assisted Gait Training
F Di Tommaso, M Ferrara, F Patarini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 19, 2010
Tremelimumab in combination with exemestane in patients with advanced breast cancer and treatment-associated modulation of inducible costimulator expression on patient T cells
Robert H Vonderheide, Patricia M LoRusso, Magi Khalil, et al.
Oncotarget
|
December 2, 2016
Phase I study of the gamma secretase inhibitor PF-03084014 in combination with docetaxel in patients with advanced triple-negative breast cancer
Marzia A Locatelli, Philippe Aftimos, E Claire Dees, et al.
Investigational New Drugs
|
February 6, 2017
Phase 1 study of narnatumab, an anti-RON receptor monoclonal antibody, in patients with advanced solid tumors
Patricia M LoRusso, Mrinal Gounder, Shadia I Jalal, et al.
Cancer Chemotherapy and Pharmacology
|
January 22, 2016
A pharmacodynamically guided dose selection of PF-00337210 in a phase I study in patients with advanced solid tumors
Justine Yang Bruce, Patricia M LoRusso, Priscila H Goncalves, et al.
Oncotarget
|
February 14, 2018
Nonlinear mixed effects dose response modeling in high throughput drug screens: application to melanoma cell line analysis
Kuan-Fu Ding, Emanuel F Petricoin, Darren Finlay, et al.
Investigational New Drugs
|
December 2, 2015
A phase I study of MK-5108, an oral aurora a kinase inhibitor, administered both as monotherapy and in combination with docetaxel, in patients with advanced or refractory solid tumors
Manik Amin, Susan E Minton, Patricia M LoRusso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2004
Magnetic resonance imaging measurements of the response of murine and human tumors to the vascular-targeting agent ZD6126
Jeffrey L Evelhoch, Patricia M LoRusso, Zhanquan He, et al.
Page
of 28
Search research articles
Search
Showing results (191-200 of 280) with videos related to
Sort By:
Page
of 28
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 16, 2010
A first-in-human study of conatumumab in adult patients with advanced solid tumors
Roy S Herbst, Razelle Kurzrock, David S Hong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 11, 2010
Phase I pharmacokinetic and pharmacodynamic study of the oral MAPK/ERK kinase inhibitor PD-0325901 in patients with advanced cancers
Patricia M LoRusso, Smitha S Krishnamurthi, John J Rinehart, et al.
IEEE ... International Conference on Rehabilitation Robotics : [Proceedings]
|
July 11, 2025
Effects of Visual and Verbal Feedback on Active Patient Participation During Robot-Assisted Gait Training
F Di Tommaso, M Ferrara, F Patarini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 19, 2010
Tremelimumab in combination with exemestane in patients with advanced breast cancer and treatment-associated modulation of inducible costimulator expression on patient T cells
Robert H Vonderheide, Patricia M LoRusso, Magi Khalil, et al.
Oncotarget
|
December 2, 2016
Phase I study of the gamma secretase inhibitor PF-03084014 in combination with docetaxel in patients with advanced triple-negative breast cancer
Marzia A Locatelli, Philippe Aftimos, E Claire Dees, et al.
Investigational New Drugs
|
February 6, 2017
Phase 1 study of narnatumab, an anti-RON receptor monoclonal antibody, in patients with advanced solid tumors
Patricia M LoRusso, Mrinal Gounder, Shadia I Jalal, et al.
Cancer Chemotherapy and Pharmacology
|
January 22, 2016
A pharmacodynamically guided dose selection of PF-00337210 in a phase I study in patients with advanced solid tumors
Justine Yang Bruce, Patricia M LoRusso, Priscila H Goncalves, et al.
Oncotarget
|
February 14, 2018
Nonlinear mixed effects dose response modeling in high throughput drug screens: application to melanoma cell line analysis
Kuan-Fu Ding, Emanuel F Petricoin, Darren Finlay, et al.
Investigational New Drugs
|
December 2, 2015
A phase I study of MK-5108, an oral aurora a kinase inhibitor, administered both as monotherapy and in combination with docetaxel, in patients with advanced or refractory solid tumors
Manik Amin, Susan E Minton, Patricia M LoRusso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2004
Magnetic resonance imaging measurements of the response of murine and human tumors to the vascular-targeting agent ZD6126
Jeffrey L Evelhoch, Patricia M LoRusso, Zhanquan He, et al.
Page
of 28